Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes - Radioactive & Nonradioactive

Evaluation of 68Ga-labeled iNGR peptide with tumor penetrating motif for microPET imaging of CD13-positive tumor xenografts

Mingxuan Zhao, Fei Kang, Mingru Zhang, Shengjun Wang, Weidong Yang and Jing Wang
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 1157;
Mingxuan Zhao
1Department of Nuclear Medicine, Xijing Hospital, Xi'an, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fei Kang
1Department of Nuclear Medicine, Xijing Hospital, Xi'an, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mingru Zhang
1Department of Nuclear Medicine, Xijing Hospital, Xi'an, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shengjun Wang
1Department of Nuclear Medicine, Xijing Hospital, Xi'an, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Weidong Yang
1Department of Nuclear Medicine, Xijing Hospital, Xi'an, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jing Wang
1Department of Nuclear Medicine, Xijing Hospital, Xi'an, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1157

Objectives To evaluate the efficacy of 68Ga-labelled iNGR peptide containing CendR tumor penetrating motif as a new molecular probe for microPET imaging of CD13-positive tumor xenografts.

Methods NGR and iNGR peptides both conjugated with NOTA were synthesised. CD13 of HT1080 and HT29 cells was confirmed by western blot and immunofluorescence. NGR and iNGR peptides were labeled by 68Ga and assayed by HPLC and stability tests. In vitro affinity to cancer cells of the two peptides was compared by competitive cell binding assays. In vivo imaging of 68Ga-NGR and 68Ga-iNGR was compared by mricoPET imaging of the same nude mouse bearing HT1080 and HT29 tumors. The in vivo CD13 affinity was verified by competitive PET imaging of the same mouse with or without cold NGR blocking. The mechanism of the theoretically improved performance of iNGR via NRP1 was verified by comparison imaging by using blockade NRP1 antibody. Tumor uptake was measured by ROI method and quantified by SUV.

Results CD13 was overexpressed in HT1080 cells but not in HT29 cells. Both probes exhibited high radiochemical purity and high stability in mouse serum or saline. The CD13 binding affinity of iNGR was comparable to that of NGR.The uptake of 68Ga-iNGR in HT1080 cells increased with incubation time, and the maximum uptake ratio was about 1.78±0.04% in HT1080 cells after 2h incubation, about 2-fold higher than that of 68Ga-NGR. In vivo imaging showed that the HT-1080 tumors were of higher contrast to HT29 tumors at all time points after injection of 68Ga-iNGR or 68Ga-NGR. The HT1080 tumor uptake of 68Ga-iNGR was significantly higher than that of 68Ga−NGR. Moreover, tumor 68Ga-iNGR uptake could be completely blocked by cold NGR and partly blocked by NRP1 antibody. Immunohistochemistry confirmed CD13 and NRP1 overexpression in HT1080 tumor neovasculature.

Conclusions 68Ga-iNGR demonstrated higher tumor uptake and better tumor retention than 68Ga-NGR through NRP1, indicating the CendR motif modification is a promising way for improving NGR peptides performance.

Research Support This work was supported by the National Natural Science Foundation of China (Grant Nos. 81230033, 81227901, 81090270, 81371594, 81401442), the National Basic Research Program of China (973 Program) (Grant No. 2011CB707704).

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 56, Issue supplement 3
May 1, 2015
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Evaluation of 68Ga-labeled iNGR peptide with tumor penetrating motif for microPET imaging of CD13-positive tumor xenografts
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Evaluation of 68Ga-labeled iNGR peptide with tumor penetrating motif for microPET imaging of CD13-positive tumor xenografts
Mingxuan Zhao, Fei Kang, Mingru Zhang, Shengjun Wang, Weidong Yang, Jing Wang
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 1157;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Evaluation of 68Ga-labeled iNGR peptide with tumor penetrating motif for microPET imaging of CD13-positive tumor xenografts
Mingxuan Zhao, Fei Kang, Mingru Zhang, Shengjun Wang, Weidong Yang, Jing Wang
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 1157;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes - Radioactive & Nonradioactive

  • Relationships between tau, atrophy, regional brain activity and connectivity in Alzheimer's disease: a PET/MRI multimodal study
  • Gray matter structural networks related to 18F-THK5351 retention in cognitively normal older adults and early Alzheimer’s disease patients
  • Assessment of α4β2 nicotinic acetylcholine receptor (nAChR) availability and neuronal response to rewarding food-cues in human obesity using simultaneous PET-MRI
Show more Molecular Targeting Probes - Radioactive & Nonradioactive

Special MTA: Preclinical Probes for Oncology Posters

  • Fluorescence imaging of prostate cancer in living mice using a new mitochondrial-derived peptide
  • Uptake of TCP-1 peptide labeled with a near-infrared dye in xenografted human colon cancer and tumor-associated vasculature
  • Small-molecule drug conjugates for theranostics of prostate cancer
Show more Special MTA: Preclinical Probes for Oncology Posters

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire